A Study of Purified Inactivated Zika Virus Vaccine (PIZV) in Healthy Adults

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 2, 2024

Primary Completion Date

July 5, 2024

Study Completion Date

July 5, 2024

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

Purified Inactivated Zika Virus Vaccine (PIZV)

PIZV vaccine with aluminium hydroxide adjuvant IM injection.

OTHER

Placebo

Placebo (normal saline (0.9% NaCl) IM injection.

Trial Locations (5)

33334

CenExel Research Centers of America, Oakland Park

40509

AMR Lexington, Formerly Central Kentucky Research Associates, an AMR company, Lexington

64114

Alliance for Multispecialty Research, LLC, Kansas City

67207

AMR East Wichita, Formerly Heartland Associates East Wichita, an AMR company, Wichita

83642

Velocity Clinical Research, Boise, Meridian

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY